Moreover, a growth factor structurally similar to insulin peptide, called Insulin Like Growth factor type 1 (IGF-1), is inversely associated with all-cause mortality in men affected by prostate cancer [26] if fact it is a candidate prognostic marker in patients affected by advanced disease. The gene discussed is INS; the disease is prostate carcinoma.